Bronchial allergen challenge using the Medicaid dosimeter

International Archives of Allergy and Immunology

Volumn 157, Issue 1, 2011, Pages 89-97

  Schulze, Johannes ^a   Rosewich, Martin ^a   Dressler, Melanie ^a   Riemer, Carsten ^a   Rose, Markus A ^a   Zielen, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Bronchial allergen challenge; Early asthmatic response; Exhaled nitric oxide; Late asthmatic response; Reproducibility

Indexed keywords

ALLERGEN; NITRIC OXIDE;

ADULT; ALLERGY TEST; ARTICLE; BRONCHUS; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DOSIMETER; FEMALE; FORCED EXPIRATORY VOLUME; GRASS POLLEN; HUMAN; MALE; MEDICAID; POLLEN ALLERGY; PRIORITY JOURNAL; REPRODUCIBILITY; SKIN TEST;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; BRONCHIAL PROVOCATION TESTS; FEMALE; HUMANS; MALE; METERED DOSE INHALERS; POACEAE; POLLEN; REPRODUCIBILITY OF RESULTS; SKIN TESTS; YOUNG ADULT;

EID: 80052601231     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000324473     Document Type: Article

References (36)

1. Taylor DA, Harris JG, O'Connor BJ: Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients. Clin Exp Allergy 2000; 30: 56-63. (Pubitemid 30093881)
2. Boulet LP, Gauvreau G, Boulay ME, O'Byrne P, Cockcroft DW: The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies. Allergy 2007; 62: 1101-1110. (Pubitemid 47374030)
3. Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM: Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med 2008; 177: 952-958. (Pubitemid 351717588)
4. Gauvreau GM, Becker AB, Boulet LP, Chakir J, Fick RB, Greene WL, Killian KJ, O'byrne PM, Reid JK, Cockcroft DW: The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2003; 112: 331-338. (Pubitemid 36981373)
5. Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA: The effect of an anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997; 155: 1828-1834. (Pubitemid 27256105)
6. Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA, Seidenberg BC, Zwinderman AH, Peszek I, Sterk PJ: The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999; 29: 42-51. (Pubitemid 29067651)
7. Rosewich M, Rose MA, Eickmeier O, Travaci M, Kitz R, Zielen S: Montelukast as add-on therapy to beta-agonists and late airway response. Eur Respir J 2007; 30: 56-61. (Pubitemid 47074006)
8. van Rensen EL, Evertse CE, van Schadewijk WA, van Wijngaarden S, Ayre G, Mauad T, Hiemstra PS, Sterk PJ, Rabe KF: Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment. Allergy 2009; 64: 72-80.
9. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE: Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis 1987; 135: 264-267. (Pubitemid 17010674)
10. Kopferschmitt-Kubler MC, Bigot H, Pauli G: Allergen bronchial challenge tests: variability and reproducibility of the early response. J Allergy Clin Immunol 1987; 80: 730-740. (Pubitemid 18025841)
11. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JL: Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 16(suppl):53-83.
12. Schulze J, Rosewich M, Riemer C, Dressler M, Rose MA, Zielen S: Methacholine challenge -comparison of an ATS protocol to a new rapid single concentration technique. Respir Med 2009; 103: 1898-1903.
13. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG: Standardisation of bronchial bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
14. Evans DJ, Barnes PJ, Spaethe SM, van Alstyne EL, Mitchell MI, O'Connor BJ: Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma. Thorax 1996; 51: 1178-1184. (Pubitemid 26413134)
15. O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT: Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergeninduced bronchoconstriction. Am Rev Respir Dis 1993; 147: 1431-1435. (Pubitemid 23160540)
16. Gauvreau GM, Watson RM, Rerecich TJ, Baswick E, Inman MD, O'Byrne PM: Repeatability of allergen-induced airway inflammation. J Allergy Clin Immunol 1999; 104: 66-71. (Pubitemid 29364481)
17. Inman MD, Watson R, Cockcroft DW, Wong BJ, Hargreave FE, O'Byrne PM: Reproducibility of allergen-induced early and late asthmatic responses. J Allergy Clin Immunol 1995; 95: 1191-1195.
18. Wasserfallen JB, Leuenberger P: Comparison between incremental and single-dose allergen administration in bronchial provocation tests. J Asthma 1996; 33: 169-178. (Pubitemid 26193543)
19. Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, Barnes PJ: Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999; 13: 48-52. (Pubitemid 29079218)
20. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ : Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995; 151: 1894-1899.
21. Lo?hagen O, Lindholm NB: Standardized allergen provocation test. Variation in bronchial response. Allergy 1980; 35: 349-356.
22. Standaert TA, Bohn SE, Aitken ML, Ramsey B: The equivalence of compressor pressureflow relationships with respect to jet nebulizer aerosolization characteristics. J Aerosol Med 2001; 14: 31-42. (Pubitemid 32428967)
23. Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, Sommerer PC, Moskovits J, Alberternst H, Böhles HJ, Schulze J, Zielen S: Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol 2009; 148: 321-329.
24. Eiser NM, Kerrebijn KF, Quanjer PH, editors: Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstriction agents. Bull Eur Physiopathol Respir 1983; 19: 495-514. (Pubitemid 14242119)
25. Brusasco V, Crapo R, Viegi G, editors: ATS/ ERS Task Force: Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
26. Recommendations for standardized procedures for the online and off-line measurement of exhaled lower nitric oxide and nasal nitric oxide in adults and children -1999. The official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160: 2104-2117.
27. Bland JM, Altman DG: Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 2003; 22: 85-93. (Pubitemid 36886457)
28. Moscato G, Dellabianca A, Paggiaro P, Bertoletti R, Corsico A, Perfetti L: Peak expiratory flow monitoring and airway response to specific bronchial provocation tests in asthmatics. Monaldi Arch Chest Dis;1993; 48: 23-28. (Pubitemid 23155298)
29. Bérubé D, Cartier A, L'Archevêque J, Ghezzo H, Malo JL: Comparison of peak expiratory flow rate and FEV1 in assessing bronchomotor tone after challenges with occupational sensitizers. Chest 1991; 99: 831-836.
30. Hatzivlassiou M, Grainge C, Kehagia V, Lau L, Howarth PH: The allergen specificity of the late asthmatic reaction. Allergy 2009 DOI: 10.1111/j.1398-9995.2009.02184.
31. Froølund L, Madsen F, Scharling B, Heinig JH, Svendsen UG: Bronchial allergen challenge: dose versus concentration. Clin Exp Allergy 1992; 22: 219-225.
32. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC: Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006; 61: 817-827. (Pubitemid 44369409)
33. Bergmann-Hug K, Wirth R, Henseler M, Helbling A, Pichler WJ, Schnyder B: Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide. Allergy 2009; 64: 1629-1634.
34. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP: Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000; 106: 904-910.
35. Boulay ME, Boulet LP: Lower airway inflammatory responses to repeated very-low-dose allergen challenge in allergic rhinitis and asthma. Clin Exp Allergy 2002; 32: 1441-1447.
36. Lam S, al-Majed S, Chan H, Tse K, LeRiche JC, Chan-Yeung M: Differences in mediator release between allergic rhinitis and asthma. J Allergy Clin Immunol 1991; 87: 842-849.